Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splinting After CCH Injection for Dupuytren Contracture
NCT04874870Phase 3Completed
- Sponsor
- Foundation for Orthopaedic Research and Education
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Foundation for Orthopaedic Research and Education. Primary endpoints: Improvement in active extension deficit of MCP joint at 4 months, Improvement in active extension deficit of PIP joint at 4 months and 1 more. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT04874870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874870.